Related references
Note: Only part of the references are listed.Hybrid core-shell particles for mRNA systemic delivery
Valentina Andretto et al.
JOURNAL OF CONTROLLED RELEASE (2023)
Fatal cytokine release syndrome by an aberrant FLIP/STAT3 axis
Chiara Musiu et al.
CELL DEATH AND DIFFERENTIATION (2022)
Optimizing synthetic nucleic acid and protein nanocarriers: The chemical evolution approach
Franziska Freitag et al.
ADVANCED DRUG DELIVERY REVIEWS (2021)
Clinical Practice of Adalimumab and Infliximab Biosimilar Treatment in Adult Patients With Crohn's Disease
Walter Reinisch et al.
INFLAMMATORY BOWEL DISEASES (2021)
A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis
Christina Krienke et al.
SCIENCE (2021)
Moonlighting Proteins Are Important Players in Cancer Immunology
Annalisa Adamo et al.
FRONTIERS IN IMMUNOLOGY (2021)
Nanocomposite systems for precise oral delivery of drugs and biologics
Valentina Andretto et al.
DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2021)
From intravenous to subcutaneous infliximab in patients with inflammatory bowel disease: a pandemic-driven initiative
Ajay M Verma et al.
Lancet Gastroenterology & Hepatology (2021)
How could nanobiotechnology improve treatment outcomes of anti-TNF-α therapy in inflammatory bowel disease? Current knowledge, future directions
Piotr Eder et al.
JOURNAL OF NANOBIOTECHNOLOGY (2021)
The Limitless Future of RNA Therapeutics
Tulsi Ram Damase et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2021)
Nanomedicine-based delivery strategies for nucleic acid gene inhibitors in inflammatory diseases
Elias Fattal et al.
ADVANCED DRUG DELIVERY REVIEWS (2021)
Insights into the biology and therapeutic implications of TNF and regulatory T cells
Benoit L. Salomon
NATURE REVIEWS RHEUMATOLOGY (2021)
Reframing Immune-Mediated Inflammatory Diseases through Signature Cytokine Hubs
Georg Schett et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Molecular biology of autoinflammatory diseases
Junya Masumoto et al.
INFLAMMATION AND REGENERATION (2021)
Therapeutic potential of TNFa inhibitors in chronic inflammatory disorders: Past and future
Hongtao Zhang et al.
GENES & DISEASES (2021)
Clinical Practice of Adalimumab and Infliximab Biosimilar Treatment in Adult Patients With Crohn's Disease
Walter Reinisch et al.
INFLAMMATORY BOWEL DISEASES (2021)
Regulatory T Cells and Human Disease
Shimon Sakaguchi et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 38 (2020)
Topical Therapy with Antisense Tumor Necrosis Factor Alpha Using Novel β-Glucan-Based Drug Delivery System Ameliorates Intestinal Inflammation
Hideto Sakisaka et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Innate immunity as the trigger of systemic autoimmune diseases
Victoria Saferding et al.
JOURNAL OF AUTOIMMUNITY (2020)
Anti-TNF-α Agents in Inflammatory Bowel Disease and Course of COVID-19
Antonio Tursi et al.
INFLAMMATORY BOWEL DISEASES (2020)
Cyclodextrins in drug delivery: applications in gene and combination therapy
Rebecca M. Haley et al.
DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2020)
Management of IBD during the COVID-19 outbreak: resetting clinical priorities
Silvio Danese et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)
Prospects for the potential of RNA interference in the treatment of autoimmune diseases: Small interfering RNAs in the spotlight
Armita Mahdavi Gorabi et al.
JOURNAL OF AUTOIMMUNITY (2020)
Review: Local Tumor Necrosis Factor-α Inhibition in Inflammatory Bowel Disease
Bahez Gareb et al.
PHARMACEUTICS (2020)
Paving the Road for RNA Therapeutics
Niels Dammes et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2020)
Personalizing Treatment in IBD: Hype or Reality in 2020? Can We Predict Response to Anti-TNF?
Raja Atreya et al.
FRONTIERS IN MEDICINE (2020)
Cytokine Storm
David C. Fajgenbaum et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Understanding and Minimising Injection-Site Pain Following Subcutaneous Administration of Biologics: A Narrative Review
Anja St Clair-Jones et al.
RHEUMATOLOGY AND THERAPY (2020)
How mRNA therapeutics are entering the monoclonal antibody field
Lien Van Hoecke et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2019)
Autoinflammatory Disorders: A Review and Update on Pathogenesis and Treatment
Annika Havnaer et al.
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2019)
Gene Therapy Leaves a Vicious Cycle
Reena Goswami et al.
FRONTIERS IN ONCOLOGY (2019)
The relationship between serum adalimumab and corresponding anti-adalimumab antibody levels: analysis of over 20,000 patient results
Chun Kelly et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2019)
Recent Advances in Chitosan-Based Carriers for Gene Delivery
Ye Cao et al.
MARINE DRUGS (2019)
Diversity, Mechanisms, and Significance of Macrophage Plasticity
Massimo Locati et al.
Annual Review of Pathology-Mechanisms of Disease (2019)
Pyroptosis versus necroptosis: similarities, differences, and crosstalk
Daniel Frank et al.
CELL DEATH AND DIFFERENTIATION (2019)
The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs
Akin Akinc et al.
NATURE NANOTECHNOLOGY (2019)
Cytokine Targeting by miRNAs in Autoimmune Diseases
Valentina Salvi et al.
FRONTIERS IN IMMUNOLOGY (2019)
Remicade® (infliximab): 20 years of contributions to science and medicine
Richard Melsheimer et al.
BIOLOGICS-TARGETS & THERAPY (2019)
Chemical modifications of nucleic acid drugs and their delivery systems for gene-based therapy
Changmai Chen et al.
MEDICINAL RESEARCH REVIEWS (2018)
A20/Tumor necrosis Factor α-induced Protein 3 in immune Cells Controls Development of Autoinflammation and Autoimmunity: Lessons from Mouse Models
Tridib Das et al.
FRONTIERS IN IMMUNOLOGY (2018)
Cobomarsen, an oligonucleotide inhibitor of miR-155, co-ordinately regulates multiple survival pathways to reduce cellular proliferation and survival in cutaneous T-cell lymphoma
Anita G. Seto et al.
BRITISH JOURNAL OF HAEMATOLOGY (2018)
TNFα gene silencing mediated by orally targeted nanoparticles combined with interleukin-22 for synergistic combination therapy of ulcerative colitis
Bo Xiao et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Orally targeted galactosylated chitosan poly(lactic-co-glycolic acid) nanoparticles loaded with TNF-α siRNA provide a novel strategy for the experimental treatment of ulcerative colitis
Yuzhe Huang et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2018)
A Dual Targeting Dendrimer-Mediated siRNA Delivery System for Effective Gene Silencing in Cancer Therapy
Yiwen Dong et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2018)
Induction of immunosuppressive functions and NF-kappa B by FLIP in monocytes
Alessandra Fiore et al.
NATURE COMMUNICATIONS (2018)
Nanoparticulate drug delivery systems targeting inflammation for treatment of inflammatory bowel disease
Sufeng Zhang et al.
NANO TODAY (2017)
Elimination of large tumors in mice by mRNA-encoded bispecific antibodies
Christiane R. Stadler et al.
NATURE MEDICINE (2017)
Current and emerging therapeutic targets for IBD
Markus F. Neurath
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2017)
Administration of nucleoside-modified mRNA encoding broadly neutralizing antibody protects humanized mice from HIV-1 challenge
Norbert Pardi et al.
NATURE COMMUNICATIONS (2017)
Tolerance through education: How Tolerogenic Dendritic Cells Shape immunity
Matthias P. Domogalla et al.
FRONTIERS IN IMMUNOLOGY (2017)
NF-κB Pathway in Autoinflammatory Diseases: Dysregulation of Protein Modifications by Ubiquitin Defines a New Category of Autoinflammatory Diseases
Ivona Aksentijevich et al.
FRONTIERS IN IMMUNOLOGY (2017)
mRNA mediates passive vaccination against infectious agents, toxins, and tumors
Moritz Thran et al.
EMBO MOLECULAR MEDICINE (2017)
Mechanisms of central tolerance for B cells
David Nemazee
NATURE REVIEWS IMMUNOLOGY (2017)
Enzyme- and pH-Responsive Microencapsulated Nanogels for Oral Delivery of siRNA to Induce TNF-α Knockdown in the Intestine
Jennifer M. Knipe et al.
BIOMACROMOLECULES (2016)
Recent innovations in mRNA vaccines
Jeffrey B. Ulmer et al.
CURRENT OPINION IN IMMUNOLOGY (2016)
The Proteomic Landscape of Human Ex Vivo Regulatory and Conventional T Cells Reveals Specific Metabolic Requirements (vol 44, pg 406, 2016)
Claudio Procaccini et al.
IMMUNITY (2016)
Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy
Lena M. Kranz et al.
NATURE (2016)
Immune checkpoints and rheumatic diseases: what can cancer immunotherapy teach us?
Michiel van der Vlist et al.
NATURE REVIEWS RHEUMATOLOGY (2016)
T cell receptor signalling in the control of regulatory T cell differentiation and function
Ming O. Li et al.
NATURE REVIEWS IMMUNOLOGY (2016)
Inflammasomes: mechanism of assembly, regulation and signalling
Petr Broz et al.
NATURE REVIEWS IMMUNOLOGY (2016)
Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
Padmanee Sharma et al.
CELL (2015)
Regulatory T cells turn pathogenic
Jitao Guo et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2015)
Mechanisms of human autoimmunity
Michael D. Rosenblum et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Dual TNF-α/IL-12p40 Interference as a Strategy to Protect Against Colitis Based on miR-16 Precursors With Macrophage Targeting Vectors
Zhen Huang et al.
MOLECULAR THERAPY (2015)
Regulatory T cells generated early in life play a distinct role in maintaining self-tolerance
Siyoung Yang et al.
SCIENCE (2015)
ANTI-TNF AGENTS AS THERAPEUTIC CHOICE IN IMMUNE-MEDIATED INFLAMMATORY DISEASES: FOCUS ON ADALIMUMAB
A. Armuzzi et al.
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2014)
Fab'-bearing siRNA TNFα-loaded nanoparticles targeted to colonic macrophages offer an effective therapy for experimental colitis
Hamed Laroui et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Cytokines in inflammatory bowel disease
Markus F. Neurath
NATURE REVIEWS IMMUNOLOGY (2014)
The Dendritic Cell Lineage: Ontogeny and Function of Dendritic Cells and Their Subsets in the Steady State and the Inflamed Setting
Miriam Merad et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)
Multifunctional polymeric nanoparticles for oral delivery of TNF-α siRNA to macrophages
Chunbai He et al.
BIOMATERIALS (2013)
Galactosylated trimethyl chitosan-cysteine nanoparticles loaded with Map4k4 siRNA for targeting activated macrophages
Jing Zhang et al.
BIOMATERIALS (2013)
Mannosylated bioreducible nanoparticle-mediated macrophage-specific TNF-α RNA interference for IBD therapy
Bo Xiao et al.
BIOMATERIALS (2013)
Current immunotherapy in rheumatoid arthritis
Florian M. P. Meier et al.
IMMUNOTHERAPY (2013)
Gene silencing of TNF-alpha in a murine model of acute colitis using a modified cyclodextrin delivery system
J. McCarthy et al.
JOURNAL OF CONTROLLED RELEASE (2013)
A rheostat for immune responses: the unique properties of PD-1 and their advantages for clinical application
Taku Okazaki et al.
NATURE IMMUNOLOGY (2013)
Immunogenicity of anti-TNF biologic therapies for rheumatoid arthritis
Pauline A. van Schouwenburg et al.
NATURE REVIEWS RHEUMATOLOGY (2013)
The role of dendritic cells in autoimmunity
Dipyaman Ganguly et al.
NATURE REVIEWS IMMUNOLOGY (2013)
Golimumab Pharmacokinetics After Repeated Subcutaneous and Intravenous Administrations in Patients with Rheumatoid Arthritis and the Effect of Concomitant Methotrexate: An Open-Label, Randomized Study
Yanli Zhuang et al.
CLINICAL THERAPEUTICS (2012)
Induction of psoriasis with anti-TNF agents in patients with inflammatory bowel disease: A report of 21 cases
Ivan Guerra et al.
JOURNAL OF CROHNS & COLITIS (2012)
Canadian Rheumatology Association Recommendations for the Pharmacological Management of Rheumatoid Arthritis with Traditional and Biologic Disease-modifying Antirheumatic Drugs: Part II Safety
Claire Bombardier et al.
JOURNAL OF RHEUMATOLOGY (2012)
Functionally Enhanced siRNA Targeting TNFα Attenuates DSS-induced Colitis and TLR-mediated Immunostimulation in Mice
Sandra M. Ocampo et al.
MOLECULAR THERAPY (2012)
Molecular mechanisms of Treg-mediated T cell suppression
Angelika Schmidt et al.
FRONTIERS IN IMMUNOLOGY (2012)
Human FoxP3+ regulatory T cells in systemic autoimmune diseases
Makoto Miyara et al.
AUTOIMMUNITY REVIEWS (2011)
Functional TNFα gene silencing mediated by polyethyleneimine/TNFα siRNA nanocomplexes in inflamed colon
Hamed Laroui et al.
BIOMATERIALS (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
In vivo nucleic acid delivery with PEI and its derivatives: current status and perspectives
Wing-Fu Lai
EXPERT REVIEW OF MEDICAL DEVICES (2011)
The risk of infection and malignancy with tumor necrosis factor antagonists in adults with psoriatic disease: A systematic review and meta-analysis of randomized controlled trials
Erica D. Dommasch et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2011)
Identification of T helper type 1-like, Foxp3+ regulatory T cells in human autoimmune disease
Margarita Dominguez-Villar et al.
NATURE MEDICINE (2011)
Tumor Necrosis Factor-a Signaling in Macrophages
Narayanan Parameswaran et al.
CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION (2010)
Targeting delivery of anti-TNF alpha oligonucleotide into activated colonic macrophages protects against experimental colitis
Longsheng Zuo et al.
GUT (2010)
Expression of αvβ8 integrin on dendritic cells regulates Th17 cell development and experimental autoimmune encephalomyelitis in mice
Andrew C. Melton et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Subcutaneous Bioavailability of Golimumab at 3 Different Injection Sites in Healthy Subjects
Zhenhua Xu et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Dendritic Cell (DC)-Specific Targeting Reveals Stat3 as a Negative Regulator of DC Function
Jessica A. Meliilo et al.
JOURNAL OF IMMUNOLOGY (2010)
Taming tissue-specific T cells: CTLA-4 reins in self-reactive T cells
Alison M. Paterson et al.
NATURE IMMUNOLOGY (2010)
Orally delivered thioketal nanoparticles loaded with TNF-α-siRNA target inflammation and inhibit gene expression in the intestines
D. Scott Wilson et al.
NATURE MATERIALS (2010)
Numbers of CD25+Foxp3+ T cells that lack the IL-7 receptor are increased intra-articularly and have impaired suppressive function in RA patients
Joel A. G. van Roon et al.
RHEUMATOLOGY (2010)
Orally delivered siRNA targeting macrophage Map4k4 suppresses systemic inflammation
Myriam Aouadi et al.
NATURE (2009)
Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo
Xuyu Zhou et al.
NATURE IMMUNOLOGY (2009)
Osteoimmunology and the effects of the immune system on bone
Hiroshi Takayanagi
NATURE REVIEWS RHEUMATOLOGY (2009)
Rheumatoid arthritis synovium contains two subsets of CD83-DC-LAMP- dendritic cells with distinct cytokine profiles
M. Cristina Lebre et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
TNF alpha blockade in human diseases: An overview of efficacy and safety
Jan Lin et al.
CLINICAL IMMUNOLOGY (2008)
Quantitative and qualitative deficiencies of regulatory T cells in patients with systemic lupus erythematosus (SLE)
Michael Bonelli et al.
INTERNATIONAL IMMUNOLOGY (2008)
Certolizumab pegol
Gil Y. Melmed et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
Tumor necrosis factor antagonist mechanisms of action: A comprehensive review
Daniel Tracey et al.
PHARMACOLOGY & THERAPEUTICS (2008)
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2007
D. E. Furst et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Loss of integrin αvβ8 on dendritic cells causes autoimmunity and colitis in mice
Mark A. Travis et al.
NATURE (2007)
How TNF was recognized as a key mechanism of disease
Ian A. Clark
CYTOKINE & GROWTH FACTOR REVIEWS (2007)
Engineering mucosal RNA interference in vivo
Yingjie Zhang et al.
MOLECULAR THERAPY (2006)
A proposed classification of the immunological diseases
Dennis McGonagle et al.
PLOS MEDICINE (2006)
Guillain-Barre and Miller Fisher syndromes occurring with tumor necrosis factor α antagonist therapy
In-Sook J. Shin et al.
ARTHRITIS AND RHEUMATISM (2006)
Anti-TNF-alpha antibody therapies in autoimmune diseases
Kokona Chatzantoni et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2006)
Signalling pathways and molecular interactions of NOD1 and NOD2
W Strober et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Tumour necrosis factor inhibitors
PT Nash et al.
MEDICAL JOURNAL OF AUSTRALIA (2005)
Defective suppressor function in CD4(+)CD25(+) T-cells from patients with type 1 diabetes
S Lindley et al.
DIABETES (2005)
Carbon monoxide produced by heme oxygenase-1 suppresses T cell proliferation via inhibition of IL-2 production
HO Pae et al.
JOURNAL OF IMMUNOLOGY (2004)
Historical review: Cytokines as therapeutics and targets of therapeutics
J Vilcek et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2004)
Characterization and recruitment of plasmacytoid dendritic cells in synovial fluid and tissue of patients with chronic inflammatory arthritis
R Lande et al.
JOURNAL OF IMMUNOLOGY (2004)
Antibody pharmacokinetics and pharmacodynamics
ED Lobo et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2004)
Progress in antisense technology
ST Crooke
ANNUAL REVIEW OF MEDICINE (2004)
Antisense oligonucleotide blockade of tumor necrosis factor-alpha in two murine models of colitis
KJ Myers et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Adalimumab, a fully human anti-tumor necrosis factor a monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate - The ARMADA trial
ME Weinblatt et al.
ARTHRITIS AND RHEUMATISM (2003)
Treatment with infliximab (Remicade) when etanercept (Enbrel) has failed or vice versa: data from the STURE registry showing that switching tumour necrosis factor alpha blockers can make sense
R van Vollenhoven et al.
ANNALS OF THE RHEUMATIC DISEASES (2003)
Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome
HM Hoffman et al.
NATURE GENETICS (2001)
Advances in immunology - Autoimmune diseases
A Davidson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
JP Hugot et al.
NATURE (2001)
A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
Y Ogura et al.
NATURE (2001)
Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway
LE Otterbein et al.
NATURE MEDICINE (2000)
Progress and potential for gene-based medicines
MR Dyer et al.
MOLECULAR THERAPY (2000)
Share Paper
